Disease progression does not appear to be the primary cause of the difference between home and clinic visual acuity measurements
THURSDAY, Aug. 25, 2022 (HealthDay News) — Visual acuity (VA) is better when tested in the clinic versus at home, according to a research letter published online Aug. 18 in JAMA Ophthalmology.
Michael D. Crossland, Ph.D., from University College London, and colleagues compared at-home and in-clinic VA using data from the next clinic visit after the home assessment (mean time, 8.8 months) to determine whether differences are due to disease progression. The analysis included 79 adults (mean age, 55 years).
The researchers found that mean VA was 0.80 logMAR (Snellen equivalent 20/125) at home and 0.75 logMAR (Snellen equivalent 20/112) in the clinic. The mean difference between the at-home and in-clinic tests was −0.056 logMAR, with no systematic change observed with level of vision.
“We hypothesized that the poorer home VA values found by ourselves and others might be due to differences in lighting levels, differences in glare or light adaptation, difficulties in understanding the test, differences in motivation without a clinician being present, or perhaps by some psychological effect of being in their own home,” the authors write.
The Home Acuity Test was developed by two of the study authors.
Abstract/Full Text (subscription or payment may be required)
Virtual Reality-Based Digital Defocus Vision Training May Aid Myopia in Children
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer
Machine Learning Model IDs Heart Failure With Reduced Ejection Fraction Using Routine Lab Indicators
Addition of CAC to PREVENT-ASCVD Equations May Improve Predictive Utility in Certain Patients
Warning Symptoms, Clinical History Can Predict Sudden Cardiac Arrest
Micro-, Nanoplastics Detected More Often in Patients With STEMI
AI Can Accurately Detect Left Ventricular Dysfunction From Electrocardiograms
Differences in Cardiovascular Risk Factor Prevalence ID"d for South Asian Adults